معرفی
Mads Gyrd-Hansen is a Professor at the Department of Immunology and Microbiology, University of Copenhagen, where he leads research at the Skin Immunology Research Center. His work focuses on the molecular mechanisms of immune signaling, particularly in the context of ubiquitin-mediated pathways and cell death regulation.
His primary research interests include ubiquitin-mediated signalling, Inhibitor of Apoptosis proteins, and survival signalling in cancer cells. Gyrd-Hansen investigates the biological function of non-degradative ubiquitin modifications in signal transduction pathways and their role in epigenetic regulation of cellular programming and disease. His current research specifically examines the regulation of ubiquitin-mediated IkappaB kinase (IKK) signalling by Inhibitor of Apoptosis proteins.
Analysis of his recent publications reveals a strong focus on inflammatory signaling pathways, particularly those involving RIP kinases, ubiquitin modifications, and cell death mechanisms. His work spans fundamental biochemical mechanisms through to translational applications in cancer therapy and inflammatory skin conditions. The research demonstrates interdisciplinary approaches combining biochemistry, cell biology, and immunology to understand disease mechanisms.
Scientific Awards:
- Regulation of Met1-linked ubiquitin and its impact on immune function (2020) - widely recognized with coverage in 45+ news outlets, referenced in policy sources and Wikipedia pages, and discussed across multiple social media platforms
Gyrd-Hansen maintains an active research program with substantial external collaborations across multiple countries. His work has generated significant impact, with publications in high-impact journals including Nature Immunology, Immunity, EMBO Journal, and Molecular Cell. His research group at the Skin Immunology Research Center focuses on understanding the molecular basis of inflammatory responses and developing potential therapeutic interventions targeting ubiquitin signaling pathways.
